Evidence map›Paper›PMID 34252377›Full record

ArticleThe Lancet. Respiratory medicine2021

Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?

Elissa Michele Abrams, Stanley Szefler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Respiratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Environmental Health Knowledge Does Not Necessarily Translate to Action in Youth.International journal of environmental research and public health · 2023
    Article
  3. School Asthma Care During COVID-19: What We Have Learned and What We Are Learning.The journal of allergy and clinical immunology. In practice · 2022
    Article
  4. Shifts in Asthma Evaluation and Management During COVID-19.Current treatment options in allergy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elissa Michele AbramsDepartment of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, MB R2A 5L9, Canada; Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada. Electronic address: elissa.abrams@gmail.com.
Stanley SzeflerThe Breathing Institute of the Paediatric Pulmonary Section, Children's Hospital Colorado, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaCOVID-19Risk AdjustmentAnti-Asthmatic AgentsChildCommunicable Disease ControlDecision MakingDisease Transmission, InfectiousHumansMedication Therapy ManagementPatient SelectionRisk AssessmentSARS-CoV-2Anti-Asthmatic Agents

Identifiers

PMID34252377
PMCPMC8597968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.